Literature DB >> 24480537

Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation.

Elizabeth D Hood1, Michael Chorny2, Colin F Greineder3, Ivan S Alferiev2, Robert J Levy2, Vladimir R Muzykantov4.   

Abstract

Endothelial-targeted delivery of antioxidant enzymes, catalase and superoxide dismutase (SOD), is a promising strategy for protecting organs and tissues from inflammation and oxidative stress. Here we describe Protective Antioxidant Carriers for Endothelial Targeting (PACkET), the first carriers capable of targeted endothelial delivery of both catalase and SOD. PACkET formed through controlled precipitation loaded ~30% enzyme and protected it from proteolytic degradation, whereas attachment of PECAM monoclonal antibodies to surface of the enzyme-loaded carriers, achieved without adversely affecting their stability and functionality, provided targeting. Isotope tracing and microscopy showed that PACkET exhibited specific endothelial binding and internalization in vitro. Endothelial targeting of PACkET was validated in vivo by specific (vs IgG-control) accumulation in the pulmonary vasculature after intravenous injection achieving 33% of injected dose at 30 min. Catalase loaded PACkET protects endothelial cells from killing by H2O2 and alleviated the pulmonary edema and leukocyte infiltration in mouse model of endotoxin-induced lung injury, whereas SOD-loaded PACkET mitigated cytokine-induced endothelial pro-inflammatory activation and endotoxin-induced lung inflammation. These studies indicate that PACkET offers a modular approach for vascular targeting of therapeutic enzymes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidant enzymes; Inflammation; In vivo vascular targeting; Nanoparticles; Platelet endothelial cellular adhesion molecules

Mesh:

Substances:

Year:  2014        PMID: 24480537      PMCID: PMC4343528          DOI: 10.1016/j.biomaterials.2014.01.023

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  48 in total

1.  Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury.

Authors:  Benjamin D Kozower; Melpo Christofidou-Solomidou; Thomas D Sweitzer; Silvia Muro; Donald G Buerk; Charalambos C Solomides; Steven M Albelda; G Alexander Patterson; Vladimir R Muzykantov
Journal:  Nat Biotechnol       Date:  2003-03-24       Impact factor: 54.908

2.  Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress.

Authors:  Vladimir V Shuvaev; Thomas Dziubla; Rainer Wiewrodt; Vladimir R Muzykantov
Journal:  Methods Mol Biol       Date:  2004

3.  The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice.

Authors:  C M Doerschuk; W M Quinlan; N A Doyle; D C Bullard; D Vestweber; M L Jones; F Takei; P A Ward; A L Beaudet
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

4.  Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting.

Authors:  A Scherpereel; R Wiewrodt; M Christofidou-Solomidou; R Gervais; J C Murciano; S M Albelda; V R Muzykantov
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

5.  PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide.

Authors:  Thomas D Sweitzer; Anu P Thomas; Rainer Wiewrodt; Marian T Nakada; Francisco Branco; Vladimir R Muzykantov
Journal:  Free Radic Biol Med       Date:  2003-04-15       Impact factor: 7.376

6.  Polymer nanocarriers protecting active enzyme cargo against proteolysis.

Authors:  Thomas D Dziubla; Adnan Karim; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2005-02-02       Impact factor: 9.776

7.  A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1.

Authors:  Silvia Muro; Rainer Wiewrodt; Anu Thomas; Lauren Koniaris; Steven M Albelda; Vladimir R Muzykantov; Michael Koval
Journal:  J Cell Sci       Date:  2003-04-15       Impact factor: 5.285

8.  PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress.

Authors:  Melpo Christofidou-Solomidou; Arnaud Scherpereel; Rainer Wiewrodt; Kimmie Ng; Thomas Sweitzer; Evguenia Arguiri; Vladimir Shuvaev; Charalambos C Solomides; Steven M Albelda; Vladimir R Muzykantov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08       Impact factor: 5.464

9.  Leukocytes mediate acid aspiration-induced multiorgan edema.

Authors:  G Goldman; R Welbourn; J M Klausner; L Kobzik; C R Valeri; D Shepro; H B Hechtman
Journal:  Surgery       Date:  1993-07       Impact factor: 3.982

10.  Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress.

Authors:  Silvia Muro; Xiumin Cui; Christine Gajewski; Juan-Carlos Murciano; Vladimir R Muzykantov; Michael Koval
Journal:  Am J Physiol Cell Physiol       Date:  2003-07-23       Impact factor: 4.249

View more
  32 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

Review 2.  Regulation of thrombosis and vascular function by protein methionine oxidation.

Authors:  Sean X Gu; Jeff W Stevens; Steven R Lentz
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

3.  Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.

Authors:  Ann-Marie Chacko; Jingyan Han; Colin F Greineder; Blaine J Zern; John L Mikitsh; Madhura Nayak; Divya Menon; Ian H Johnston; Mortimer Poncz; David M Eckmann; Peter F Davies; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2015-07-13       Impact factor: 15.881

4.  Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Authors:  Krupa Savalia; Devika S Manickam; Erin G Rosenbaugh; Jun Tian; Iman M Ahmad; Alexander V Kabanov; Matthew C Zimmerman
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

5.  Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.

Authors:  Colin F Greineder; Carlos H Villa; Landis R Walsh; Raisa Y Kiseleva; Elizabeth D Hood; Makan Khoshnejad; Robert Warden-Rothman; Andrew Tsourkas; Vladimir R Muzykantov
Journal:  Bioconjug Chem       Date:  2017-12-29       Impact factor: 4.774

Review 6.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

Review 7.  Enzymes as Immunotherapeutics.

Authors:  Shaheen A Farhadi; Evelyn Bracho-Sanchez; Sabrina L Freeman; Benjamin G Keselowsky; Gregory A Hudalla
Journal:  Bioconjug Chem       Date:  2018-01-31       Impact factor: 4.774

Review 8.  Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

Authors:  Esther de Pablo; Raquel Fernández-García; María Paloma Ballesteros; Juan José Torrado; Dolores R Serrano
Journal:  Ann Transl Med       Date:  2017-11

Review 9.  Targeting therapeutics to endothelium: are we there yet?

Authors:  Raisa Yu Kiseleva; Patrick M Glassman; Colin F Greineder; Elizabeth D Hood; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.